CS239422B1 - Substituted benzothiazolium salts and a process for their preparation - Google Patents

Substituted benzothiazolium salts and a process for their preparation Download PDF

Info

Publication number
CS239422B1
CS239422B1 CS842570A CS257084A CS239422B1 CS 239422 B1 CS239422 B1 CS 239422B1 CS 842570 A CS842570 A CS 842570A CS 257084 A CS257084 A CS 257084A CS 239422 B1 CS239422 B1 CS 239422B1
Authority
CS
Czechoslovakia
Prior art keywords
methyl
acetone
formula
allyl
dimethylformamide
Prior art date
Application number
CS842570A
Other languages
Czech (cs)
Slovak (sk)
Other versions
CS257084A1 (en
Inventor
Viktor Sutoris
Vladimir Sekerka
Original Assignee
Viktor Sutoris
Vladimir Sekerka
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viktor Sutoris, Vladimir Sekerka filed Critical Viktor Sutoris
Priority to CS842570A priority Critical patent/CS239422B1/en
Publication of CS257084A1 publication Critical patent/CS257084A1/en
Publication of CS239422B1 publication Critical patent/CS239422B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Vynález rieSi spfisob přípravy nových látok 2-alkyltio-3-alkylbenzotiazolových solí všeobecného vzorca I kde R znamená metyl, etyl, alyl, propargyl, izobutyl; R1 znamená vodík, metyl, etyl, alyl, etoxykarbonylmetyl, benzyl, dodecyl a X” znamená Br”, I”, HSO^, alebo CH^SO^, s tým, že keí X“ je I" tak R neznamená metyl· Podstata spOsobu přípravy látok podTa vynálezu spočívá,v tom, že deriváty 2- -benzotiazolíntionu reagujá s RX, kde R a X znamená to isté, ako vo vzorci I a v prostředí organických rozpúšťadiel, ako sú nitrometán, aceton, tetrahydrofurén, dimetylformamid. zmes dimetylformamidu a acetonu (3:1) alebo bez rozpúšťadla pri teplote 18 až 110 °C po dobu 30 minút až 24 hodin. Látky podTa vynálezu sú účinné ako stimulétory alebo inhibitory rastu rastlin.The invention solves the problems of preparing new substances of 2-alkylthio-3-alkylbenzothiazole salts of general formula I where R means methyl, ethyl, allyl, propargyl, isobutyl; R1 means hydrogen, methyl, ethyl, allyl, ethoxycarbonylmethyl, benzyl, dodecyl and X" means Br", I", HSO4, or CH2SO4, with the proviso that when X" is I" then R does not mean methyl. The essence of the method for preparing the substances according to the invention lies in the fact that the 2-benzothiazolinethione derivatives react with RX, where R and X mean the same as in formula I and in the environment of organic solvents such as nitromethane, acetone, tetrahydrofuran, dimethylformamide. a mixture of dimethylformamide and acetone (3:1) or without a solvent at a temperature of 18 to 110 °C for a period of 30 minutes to 24 hours. The substances according to the invention are effective as plant growth stimulants or inhibitors.

Description

239422 2

Vynález sa týká derivátov benzotiazóliových solí obecného vzorca I

kde B znamená metyl, etyl, alyl, propargyl, izobutyl, R1 znamená vodík, metyl, etyl, alyl, etoxykarbonylmetyl, benzyl, dodecyl a X“ znamená jód, bróm, hydrosulfát, metylsulfát, spfisobu ich přípravy a účinku ako sti-mulátorov a inhibítorov rastu rastlín.

Podrobný literárny prieskum bol uvedený v práci 2-alkoxykarbonylmetyltio-3-alkyl-benzotiazóliové soli a spfisob ich přípravy (Sutoris V., Sekerka V., Sohlerová R.: AO 233 443. Z uvedených zlúčenín bol syntetizovaný, rozdielnou metodikou a v nízkomvýtažku len 2-metyltio-3-metylbenzotiazóliumjodid (Fry D. J., Kendall J. D.: J. Chem.Soc. 1951, 1 716). Ostatně benzotiazóliová soli podl*a vynálezu nie sú v literatúre do-teraz popísané a Studiu ich biologickej účinnosti nebola věnovaná žiadna pozornost.

Podstata spfisobu přípravy látok podl'a vynálezu spočívá v tom, že deriváty 3—R1—2—-benzotiazolíntiónu vzorca II C=Sdi—r1 (II) kde r' znamená to isté ako vo vzorci I, reagujú s RX, kde R a X znamená to isté, ako vovzorci I v prostředí organických rozpúětadiel, ako sú nitrometán, aceton, tetra-hydrofurán, dimetylformamid, zmes dimetylformamidu a acetonu (3:1) alebo bez roz-púšťadla pri teplote 18 až 110 °C po dobu 30 minút až 24 hodin.

Uvedenú reakciu naznačuje nasledovná schéma: s". C=Slil — R1

+ RX c — s -dl - r1 kde R, R1 a X” je horeuvedené: Všeobecné postupy přípravy 2-alkyltio-3-alkylbenzotiazóliumhalogenidov, hydrosulfátova metylsulfátov. 3 239422 Přikladl 0,03 molu 3-alkyl-2-benzotiazolíntiónu sa rozpustilo v 15 »1 nitroaetánu a po přidaní0,035 molu příslušného alkylhalogenidu sa reakčná zaes nechala stať prl laboratórnejteplete 24 hodin. Vykrystalizovaný podlel sa odfiltroval a prenyl acetónoa. Příklad 2 K 0,03 aolu 3-alkyl-2-benxotiazolíntlónu sa přidalo 0,04 aolu alkylhalogenidu areakčná zaes sa zahrlevala 4 hodiny na teplotu 70 aš 80 °C. Po přidáni suchého acetonusa pevný podlel izoloval flltréclou. Příklad 3 0,03 aolu 3-alkylbenzotlazolíntiónu sa rozpustí v 15 aš 20 al nitroaetánu, acetonu,tetrahydrofurénu, diaetylforaaaidu alebo zaesl diaetylforaaaidu a acetonu (3:1), pridésa 0,04 aolu alkylhalogenidu a reakčná zaes sa zahrieva vo vodnoa kúpeli na 60 aš 75 °Cpo dobu 10 hodin. Příklad 4 0,03 aolu 2-alkyltio-3-alkylbensotiasóliuahalogenldu sa rozpustí v 50 al vody, roztoksa přefiltruje a pridé 5 %-ný prebytok KCIO^ rozpuštěného v 15 al vody. Z bleleho zákalusa vylúCi olejovltý podlel, ktorý stétia krystalizuje. Příklad 5 K 0,03 aolu 3-*alkyl-2-benzotiazolíntlónu sa pridé 4,4 g /0,035 aolu) dlaetylsulfétua reakčná zaes sa 30 alnút aš 1 hodinu zahrieva na 60 aš 110 °C. Po vychladnutí sa pridéaceton, pevný podlel sa odfiltruje a dobré preayje acetónoa. Příklad 6 0,03 nolu 3-alkyl-2-benzotlazollntlónu sa rozpustí v 15 al acetonu a po přidaní 4,4 g(0,035 nolu) dlaetylsulfétu sa reakčná zaes zahrieva na teplotu varu reakEnej snesl 2 aš3 hodiny. Po ochladení sa isoluje krystalický podlel. Příklad 7 0,03 nolu 3-alkyl-2-benzotiazollntiónu sa rozpustí v Í5 al tetrahydrofurénu a sa nieSanlasa prlkvapké 3,4 g (0,035 aolu) HgSO^. Vylúčené krystalické létka sa čistí kryStallséciouz etanolu.

Analogické postupy sa poušijú pre přípravu alkenyl, alkinyl, etoxykarbonylaetyl abenzyl derivátov. Výsledky elementérnej analýzy a fyzlkélnochenické konstanty syntetizovaných zlúčenlnpodTa vynálezu sú uvedené v tabuPke 1. 'h-NMR spektrá bolí naaerané na přístroji Tesla BS 487 A prl 80 IIHZ v deuterovanejtrifluoroctovej kyselině, vnútorný Standard hexanetyléndlsiloxán. Výsledky sú uvedenév tabuíke 2. 239422 4 Látky podfa vynálezu sú účinné ako stlmulátory a inhibitory rastu rastlln. Baštovétesty aa uskutečnili autorml modifikovanou metodou na objekte vika siata. Přiklad 8osvetruje spdsob testovania zlúčenin pódia vynálezu na stimulačnú a lnhiblčnú účinnost. Přiklade

Semená vlky slátej klíčili v Petriho miskách v termostate, v trne prl 25 °C. Klíčencepo 48-hodinovom raste sa exponovali v molárnyeh roztokoch benzotiazóliových soliach,obecného vzorea 1, kde B, r’ a X~ znamená to isté, Testovanie sa uskutečnilo v koncentračnej Skále 10~16 až JO“1 mol. dm~3 a po 24 hodinách inkubácle bol stanovený prlrastokpredlžovacleho rastu koreňov. Při každom stanoveni bol uskutečněný aj rastový efektv kontrolněj sérii.

Ako Standardy boli testované kyselina beta-lndolyloctová (IAA) a kyselina 2,4-di-chlórfenoxyoctová (2,4-0) a 2-chlóretyltrimetylamóniumchlorid (CCC). Výsledky stimulač-ného a inhiblčného účinku syntetizovaných zlúčenin pódia vynálezu sú uvedené v tabuTke 3. 5 239422 «ρ e-3

0 <n o Φ o <— oo CM o CM CM »- M *3 *3 *q *3 0 0 0 0 0 00 Φ 00 OO CM σ» r· c— O CM <— ·— σ» cm <*> <*> ΓΗ <*> <Μ ο ο ΙΑ ΙΑ *5 0

CM Ο 0 σ\ 0 m σ\ σ\ οοο 35

σ\ Φ 00 C: LA CM 00 00 CM Φ OO O n Φ CM o CM OO *— 00 σ» 00 00 0 IA IA o CM CM CM *- ** ·“ CM CM CM Φ <*> 0 h- o 0 Φ CM 0 σ* 0 f- 0 O <n 0 CM CM CM Φ Φ (Λ lA Φ <n LA cn Φ <n 0 0 <*? c*í Φ· Φ r? <*í Φ Φ m <n c*T cn Φ φ t— t- ί- «- ΙΑ cm <*> 0 <η ί— 0 <η ο o ΙΑ Φ CM σ\ 0 0 Φ CM —· σ» σν 0 0 <η cm C- ί- 0 0 ο rO m η η φ φ <η ο m Π ΙΑ σ» — οο σχ οο οο ΙΑ m σ“» σ\ t-ια φ «~ σ\ — —cm m m ΙΑ ΙΑ t- φ φ η <ή οο 0

%. S θ' S3 r— aT" οο ο <*><- 0 φ ο* a" Ο Φ0 <η ω

_ CM

CM 0

CM m m m* Λ ω ο co mΦο φε— φφΙΑ p * Ο *

- φφ ω ια ο οοΟ ί- Ο Φ S3 CM « " a j » η ... _ _ . Η ΙΑ ΙΑΠ Αίσ* ΦίΛ t—<*Ί ΙΑ0 ' Ιαλι

ο σ> η .-φ <-σ> <-οο <*ίφ _.JX ©<ν acnamarnaína— CM *- CM 0 r~ — S CM - - ~ . * S9 S3 *- a — Š? <n a o a^· o <n a o a σ\ o

CM

O 0 Φσ\o c*>a *

— IA .-©a mo o 0 a^ o φ Φ ο Ο Φ 0 0 Ο <η • <*-> r-C a a Ο ο Η Η Ο Φ

O 0 a^ o φ o co a^ o o co a a^ o a? Ϋ a

O

aT o v a o

sP

O af

O

oN o o ď* o

lA a• 0 o a^1 o a?

O ί*Ί a o a° o a1 o a

V a o o CHgCHsCHg CH, Br C11H12BrNS2 86 43,71 4,00 4,63 21,21 107 až 110 302,25 43,48 4,33 4,34 21,18

239422 6 >> a 3 (0

P a a > o >o « - J4 s

o í*> <n n ia *· ·- >M M >N < • • n IA O <n CM IA <0 Λ 3 p w fe 3 * o ift 44

O *4 „ flf

V g? ► o © »4

O

M p 1 co

KO o O <n <Λ <n n M- CM IA (A • * »»· O O t- ř* CM CM CM CM CM CM M3 M> IA M> \O vO M- <n O to> to to to « Μ- M· < m· ΙΑ m \O CM © ř s? CM IA π η π ií\ ιλ in «0 CF „to m íS ° o osT Mo” w v o a? o m ΓΊ

<F §

CM

aT

CM <*» co t- M* CM O os ¢5 M· σ* to σ» m as < <n m o co m w o in as

CM o as ? o sf o as o

aP o as o oT* o >» 44 >

i>) >» P> f>> >j+>+>+£+>+>4> © Φ Φ © a a a e a ritii

CM CM CM CM CM 7 239422

Tabulka 2

’η-NMR chemické posuny (δ) benzotiazóliovýeh solí syntetizovaných podTa vynálezu číslo R R1 X“ I CH3 H HSO4 7,8 až 7,2 (ar, 4H, a); 2,66 (S-CH3, 3H, a) IX CH3 c»3 CH3SO4 7,8 až 7,2 (ar, 4H, b)j 3,78 (rf-CHp 3H, s)3,50 (CH3SO4, 3H, s)} 2,70 (S-CH3, 3H, s) III OT3 CH3 C1O4 7,8 až 7,2 (ar, 4H, a); 3,75 (N+-CH3, 3H, s)i2,67 (S-CH3, 3H, s) IV ch3 ch2ch=ch2 CH3SO4 7,8 až 7,2 (ar, 4H, a)j 5,5 (=CH, 1H, a); 5,0 (=CH2, 2H, b); 4,86 (N*-CH2, 2H, d); 2,71 (S-CH3, 3H, s) v CH3 ch2ch=ch2 J 7,9 až 7,2 (ar, 4H, a)j 5,6 (=CH, 1H, a){ 5,1 (=0¾. 2H, a); 4,88 (M+-CH2, 2H, d)j 2,73 (S-CH3, 3H, s) VI ch3 ch2cooc2h^ J 7,9 až 7,2 (ar, 4H, a)j 5,16 (N*-CH2, 2H, a);4,00 (0-CH2, 2H, q, J=7,4 Hz)j 2,75 (S^CHj,3H, s)} 0,91 (C-CH3,.3H, t) VII CH3 gh2c6h5 CH3SO4 7,9 až 7,2 (ar, 4H, a); 6,7 až 6,1 (Ph, 5H,5,43 (N+-CH2, 2H, s)i 3,46 (CHjSO“, 3H, s);2,69 (S-CH3, 3H, s) VIII ch3 (ch2)hch3 CH3SO4 7,9 až 7,2 (ar, 4H, a); 4,23 (B+-0H2, 2H, t)}3,49 (CH3S0" 3H, a) i 2,68 (S-CHp 3H, s); 1,8 až 0,6 (0υΗ23, 23H, a) IX C2H5 ch3 CH3SO4 7,8 až 7,2 (ar, 4H, a)i 3,79 (N*-CH3, 3H, s)j3,48 <CH3SO“, 3H, s)j 3,20 (S-CH2, 2H, q)j1,28 (C-CHp 3H, t) X CH2CH=CH2 H HS£>4 7,8 až 7,2 (ar, 4H, a); 5,9 až 5,0 (-CH^,3H, a); 3,75 (S-CH2, 2H, d) XI CH2CH=CH2 CH3 Br 7,8 až 7,2 (ar, 4H, a)j 5,8 až 5,0 (-CH-CH2,3H, a); 3,80 (S-CH2, 2H, d)j 3,78 (N+-CH3, 3H, s) XII ch2c«ch cr3 Br 7,9 až 7,2 (ar, 4H, a)} 3,95 (S-CH2, 2H, d)j3,82 (íT-Cltj, 3H, s)J 2,17 (-CH, 1H, t) XIII CHgCaCH C2H5 Br 7,9 až 7,2 (ar, 4H, a)j 4,34 (Ν+-βΗ2, 2H, q);4,00 (S-CH2, 2H, d); 2,19 (sCH, 1H, t); 1,23(c-ch3, 3H, t) XIV CH2CH(CH3)2 ch3 ch3so4 7,8 až 7,2 (ar, 4H, a); 3,78 (N+-CH3, 3H, s)j3,03 (S-CH2, 2H, d)} 1,90 (CH, 1H, n); 0,80(CH3, 6H, d) s - singlet, d - dublet, t - triplet, q - kvartet, n - nonet, a - aultiplet 239422 8

Tabulka 3

Stimule3ná a inhibičná úSinnost syntetizovaných zlúčenín podTa vynálezu číslo R r’ X" Stiaulácia mol. dm“3 Ήβη Inhibícia mol.dm“3—mni Z CH3 H HSO4 3,55 10“’3 11 CH3 ch3 CH3SO4 3,85 10“7 III CH3 ch3 C104 22,40 10“3 IV CH3 ch2ch»ch2 CH3SO4 3,60 ΙΟ’7 6,20 10“” v CH3 ch2ch=ch2 I 19,75 ,0“3 VI CH3 ch2cooc2h^ I 20,55 10“3 VII ch3 «W, CH3SO4 14,40 10“3 VIII CH3 (CH2),,CH3 CH3SO4 3,15 10“3 IX C2H5 CH3 ch3so4 5,85 io-" X ch2ch=ch2 H hso4 3,35 ΙΟ’7 XI ch2ch=ch2 ch3 Br 1,90 i°79 XII CHgCsCH ch3 Br 4,25 ,0-” XIII CHgCaCH C2«5 Br 3,45 10“’3 XIV CH2CH(CH3)2 IAA CH3 CH.S04 J 4 3,10 10“12 4,30 10-’3 2,4-D CCC 4,95 10“9 3,85 10“3 IAA - kyselina beta-indolyloctová; 2,4-D-kyselina 2,4-dichlórfenoxyoetové;CCC - 2-chlóretyltrimetylamóniumchlorid

239422 2

This invention relates to benzothiazolium salt derivatives of the formula I

wherein B is methyl, ethyl, allyl, propargyl, isobutyl, R 1 is hydrogen, methyl, ethyl, allyl, ethoxycarbonylmethyl, benzyl, dodecyl, and X "is iodine, bromine, hydrosulfate, methylsulfate, and the like; plant growth inhibitors.

A detailed literary survey was conducted in the work of 2-alkoxycarbonylmethylthio-3-alkylbenzothiazolium salt and their preparation (Sutoris V., Sekerka V., Sohler R .: AO 233 443. 2-methylthio-3-methylbenzothiazolium iodide (Fry DJ, Kendall JD: J. Chem. Soc. 1951, 1716) Moreover, the benzothiazolium salts of the invention are not yet described in the literature and no attention has been paid to their biological activity study. .

The principle of the preparation of the compounds according to the invention is that the 3-R1-2-benzothiazolinothione derivatives of formula II C = Sdi-r 1 (II) wherein r 'is the same as in formula I, react with RX where R a is X is the same as in Formula I in organic solvents such as nitromethane, acetone, tetrahydrofuran, dimethylformamide, a mixture of dimethylformamide and acetone (3: 1) or without solvent at 18-110 ° C for 30 minutes up to 24 hours.

The reaction is indicated by the following scheme: s ". C = Slil - R1

+ R x c - s -d 1 - r 1 where R, R 1 and X "are as described above: General procedures for the preparation of 2-alkylthio-3-alkylbenzothiazolium halides, hydrosulfate methylsulfates. Example 23 0.03 mole of 3-alkyl-2-benzothiazolinethone was dissolved in 15 µl of nitroaethane and after addition of 0.035 mole of the appropriate alkyl halide, the reaction was allowed to cool for 24 hours. The crystallized portion was filtered off and prenyl acetone was added. Example 2 To 0.03 aol of 3-alkyl-2-benzothiazolinone, 0.04 aol of alkyl halide was added and the mixture was heated to 70-80 ° C for 4 hours. After addition of dry acetone, the solid was isolated by filtration. EXAMPLE 3 0.03 Aol of 3-alkylbenzothlazolinothione is dissolved in 15-20 al of nitroaethane, acetone, tetrahydrofurene, diaethylforaaaid or diaethylphosphoramide and acetone (3: 1), 0.04 aol of alkyl halide is added and the reaction mixture is heated to 60 with water. up to 75 ° C for 10 hours. Example 4 Dissolve 0.03 aol of a 2-alkylthio-3-alkylbenzothiazolium halide in 50 µl of water, filter the solution and add a 5% excess of KCl 3 dissolved in 15 µl of water. From the bleached cloudiness, he drains an oil-yellow bead that crystallizes. EXAMPLE 5 4.4 g (0.035 aol) of propylene sulphate was added to 0.03 aol of 3 &apos; -alkyl-2-benzothiazolinetone and the reaction mixture was heated to 60-110 [deg.] C. for 1 hour to 1 hour. After cooling, acetone is added, the solid is filtered and the acetone is washed well. EXAMPLE 6 0.03 nol of 3-alkyl-2-benzothlazolinone is dissolved in 15 .mu.l of acetone and, after addition of 4.4 g (0.035 mol) of methylsulfate, the reaction mixture is heated to reflux for 2 to 3 hours. After cooling, the crystalline fraction is isolated. EXAMPLE 7 0.03 nol of 3-alkyl-2-benzothiazolynone was dissolved in 15 [mu] l of tetrahydrofuran and 3.4 g (0.035 aol) of HgSO4 were added dropwise. The precipitated crystalline fly is purified by ethanol crystals.

Analogous procedures are used to prepare alkenyl, alkynyl, ethoxycarbonylaethyl and benzyl derivatives. The results of the elemental analysis and the physical constant of the synthesized compounds of the invention are shown in Table 1. 1 H-NMR spectra were recorded on a Tesla BS 487 A pr180 IIHZ instrument in deuterated trifluoroacetic acid, internal Standard hexanethylenedlsiloxane. The results are shown in Table 2. 239422 4 The compounds of the invention are effective as mulifiers and growth inhibitors. The bastion tests and and were carried out by a modified method on a vika siata object. Example 8 illustrates the method of testing compounds of the invention for stimulatory and inhibitory activity. Priklade

Seeds of straw wolf germinated in Petri dishes in a thermostate, at a thorn of 25 ° C. Keying after 48-hour growth was exposed in molar solutions of benzothiazolium salts of general formula 1, where B, r 'and X ~ are the same. Testing was carried out in a concentration rock of 10 -16 to 10-mole. dm ~ 3, and after 24 hours of incubation, the growth of prolonged root growth was determined. In each determination, a growth effect was also performed in the control series.

As standards, beta-indolylacetic acid (IAA) and 2,4-dichlorophenoxyacetic acid (2,4-0) and 2-chloroethyltrimethylammonium chloride (CCC) were tested. The results of the stimulatory and inhibitory effect of the synthesized compounds of the invention are shown in Table 3. 5 239422 «ρ e-3

0 <o CM <CM o CM CM »- M * 3 * 3 * q * 3 0 0 0 0 0 00 Φ 00 OO CM σ» r · c - O CM <- · - σ »cm <* ><*> ΓΗ <*><Μ ο ο ΙΑ ΙΑ * 5 0

CM Ο 0 σ 0 m σ σ οο 35

00 C: LA CM 00 00 CM O OO O n Φ CM o CM OO * - 00 σ »00 00 IA IA CM CM CM * - ** ·“ CM CM CM Φ <*> 0 h- o 0 Φ CM 0 σ * 0 f- 0 O <n 0 CM CM CM Φ Φ (A lA n <n LA cn Φ <n 0 0 <* c * m n cm c n — t Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ Φ 0 0 0 0 0 0 C C C C C C C C C C C ί m m m m cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm cm α α η <or οο 0

%. S θ 'S3 r - aT "οο ο <*><- 0 φ ο * a" Ο Φ0 <η ω

_ CM

CM 0

CM mmm * ω ω ο what mΦο φε— φφΙΑ p * Ο *

φ ω 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 3 0 0

ο σ> η.-φ <-σ><-οο<* ίφ _.JX © <ν acnamarnaina— CM * - CM 0 r ~ - S CM - - ~. * S9 S3 * - and - S? <naoa ^ · o <naoa σ

CM

O 0 Φσ \ t

IA © a 0 0 0 0 0 0 0 0 0 0 C C C C C C C C C C

O 0 a ^ o φ o what a ^ oo what aa ^ oa? Ϋ a

O

aT ovao

sP

O af

O

oN oo ï

lA and 0 oa ^ 1 oa?

O ί * Ί aoa ° o a1 oa

V aoo CHgCHsCHg CH, Br C11H12BrNS2 86 43.71 4.00 4.63 21.21 107 to 110 302.25 43.48 4.33 4.34 21.18

239422 6 >> and 3 (0

P aa>o> o «J4 s

í>>>> · · · · · · · IA IA IA IA IA IA IA IA IA IA IA IA IA IA IA IA IA IA MM

0 * 4 'flf

In g? ► About 4

O

M p 1 co

O o O <n <n <nn M- CM IA CM * CM »CM CM CM CM CM CM M3 M> IA M> Μ- M · <m · ΙΑ m \ CM ř CM π IA IA IA in in in in in 0 CF CF CF CF

<F §

CM

aT

CM <* »co t- M * CM O axis ¢ 5 M · σ * to σ» m as <<nmo co mwo in as

CM o as? o o o o o

aP o o o * o>»44>

i>)>P> f >>> j +>+> + £ +>+>4> © a Φ © aaaea ritii

CM CM CM CM CM 239422

Table 2

η-NMR chemical shifts (δ) of the benzothiazolium salts synthesized according to the invention No. R 1 X X I 1 CH 3 H HSO 4 7.8-7.2 (ar, 4H, a); 2.66 (S-CH3, 3H, a) IX CH3C3 CH3SO4 7.8-7.2 (ar, 4H, b) 3.78 (rf-CHp3H, s) 3.50 (CH3SO4, 3H, s) 2.70 (S-CH3, 3H, s) III OT3 CH3 C1O4 7.8-7.2 (ar, 4H, a); 3.75 (N + -CH3, 3H, s) 2.67 (S-CH3, 3H, s) IV ch3 ch2ch = ch2 CH3SO4 7.8 to 7.2 (ar, 4H, a) j 5.5 (= CH, 1H, [alpha]); 5.0 (= CH2, 2H, b); 4.86 (N * -CH 2, 2H, d); 2.71 (S-CH 3, 3H, s) in CH 3 ch 2 ch = ch 2 J 7.9-7.2 (ar, 4H, a) j 5.6 (= CH, 1H, a) {5.1 (= 0¾, 2H, a); 4.88 (M + -CH 2, 2H, d); 2.73 (S-CH 3, 3H, s); 4.00 (O-CH 2, 2H, q, J = 7.4 Hz); 2.75 (S, CH 3, 3H, s); 0.91 (C-CH 3, 4H, s); 3H, t) VII CH3 gh2c6h5 CH3SO4 7.9-7.2 (ar, 4H, a); 6.7 to 6.1 (Ph, 5H, 5.43 (N + -CH 2, 2H, s); 3.46 (CH 3 SO 2, 3H, s); 2.69 (S-CH 3, 3H, s) VIII CH3 (ch2) hch3 CH3SO4 7.9-7.2 (ar, 4H, a); 4.23 (B + -0H2, 2H, t)} 3.49 (CH3SO3H, a) 2.68 (S 1.8 to 0.6 (0υΗ23, 23H, a) IX C2H5 ch3 CH3SO4 7.8-7.2 (ar, 4H, a) 3.79 (N * -CH3, 3H); , s) 3,48 <CH 3 SO ”, 3H, s) j 3.20 (S-CH 2, 2H, q) j 1.28 (C-CHp 3H, t) X CH 2 CH = CH 2 H HS £> 4 7.8 up to 7.2 (ar, 4H, a); 5.9 to 5.0 (-CH3, 3H, a); 3.75 (S-CH2, 2H, d) XI CH2CH = CH2 CH3 Br 7.8 up to 7.2 (ar, 4H, a); 5.8 to 5.0 (-CH-CH2, 3H, a); 3.80 (S-CH2, 2H, d); 3.78 (N + -CH3 , 3H, s) XII, CH 2 Cl 3 Br 7.9-7.2 (ar, 4H, a) 3.95 (S-CH 2, 2H, d) 3.82 (t-Clt, 3H, s) J 2.17 (-CH, 1H, t) XIII CH3CaCH2H5 Br 7.9-7.2 (ar, 4H, a) j 4.34 (Ν + -βΗ2, 2H, q); 4.00 (S -CH 2, 2H, d); 2.19 (sCH, 1H, t); 1.23 (c-ch 3, 3H, t) XIV CH 2 CH (CH 3) 2 ch 3 CH 3 O 4 7.8-7.2 (ar, 4H 3.78 (N + -CH 3, 3H, s) 3.03 (S-CH 2, 2H, d) 1.90 (CH, 1H, n) 0.80 (CH 3, 6H, d) s - singlet, d - doublet, t - triplet, q - quartet, n - nonet, a - ault iplet 239422 8

Table 3

Stimulating and inhibitory activity of the synthesized compounds of the present invention No. R r 'X "Molecular Dilution" 3 ηβη Mol.dm Inhibition 3 - mni Z CH 3 H HSO 4 3.55 10 "3 11 CH3 ch3 CH3SO4 3.85 10" 7 CH3 ch3 C104 22,40 10 “3 IV CH3 ch2ch» ch2 CH3SO4 3.60 ΙΟ7 7,20 10 “” in CH3 ch2ch = ch2 I 19,75, 0 “3 VI CH3 ch2cooc2h ^ I 20,55 10 "3 VII ch3« W, CH3SO4 14.40 10 "3 VIII CH3 (CH2) ,, CH3 CH3SO4 3.15 10 '3 IX C2H5 CH3 ch3so4 5.85 io-" X ch2ch = ch2 H hso4 3.35 ΙΟ " 7 XI ch2ch = ch2 ch3 Br 1.90 i ° 79 XII CHgCsCH ch3 Br 4.25, 0- ”XIII CHgCaCH C2« 5 Br 3.45 10 ”'3 XIV CH 2 CH (CH 3) 2 IAA CH 3 CH.S04 J 4 3,10 10 “12 4,30 10-'3 2,4-D CCC 4,95 10“ 9 3,85 10 “3 IAA - beta-indolylacetic acid; 2,4-D-2,4-Dichlorophenoxy-acetic acid; CCC-2-Chloroethyltrimethylammonium chloride

Claims (3)

PREDMET VYNÁLEZUOBJECT OF THE INVENTION 1. Substituované benzotiazóliové soli obecného vzorca I (I) kdeSubstituted benzothiazolium salts of the general formula I (I) wherein R znamená metyl, etyl, alyl, propargyl, izobutyl;R is methyl, ethyl, allyl, propargyl, isobutyl; r' znamená vodík, metyl, etyl, alyl, etoxykarbonylmetyl, benzyl, dodecyl, ar 'is hydrogen, methyl, ethyl, allyl, ethoxycarbonylmethyl, benzyl, dodecyl, and X“ znamená Br“, I“, HSO~, alebo CH^SO^ s tým, že ked X“je X“ tak R neznamená metyl.X "is Br", I ", HSO -, or CH 2 SO 4, provided that when X" is X ", R is not methyl. 2. Spčsob přípravy látok podTa bodu 1, vyznačený tým, že deriváty 3-R,-2-benzotiazolín tiónu vzorca XI (XI) kde2. A method according to claim 1, characterized in that the 3-R , -2-benzothiazoline thione derivatives of the formula XI (XI): R1 znamená to isté ako vo vzorci I, reagujú s RX, kde R a X“ znamená to isté ako vo vzorci X, v prostředí organických rozpúšťadiel ako sú nitrometán, aceton, tetrahydrofurén, dimetylformamid, zmes dimetylformamidu a acetonu v pomere 3:1 alebo bez rozpúšťadla pri teplote 18 až 110 °C po dobu 30 minút až 24 hodin.R 1 is the same as in formula I, reacted with RX, where R and X "is the same as in formula X, in organic solvents such as nitromethane, acetone, tetrahydrofuran, dimethylformamide, a 3: 1 mixture of dimethylformamide and acetone or without solvent at 18 to 110 ° C for 30 minutes to 24 hours.
CS842570A 1984-04-03 1984-04-03 Substituted benzothiazolium salts and a process for their preparation CS239422B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CS842570A CS239422B1 (en) 1984-04-03 1984-04-03 Substituted benzothiazolium salts and a process for their preparation

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CS842570A CS239422B1 (en) 1984-04-03 1984-04-03 Substituted benzothiazolium salts and a process for their preparation

Publications (2)

Publication Number Publication Date
CS257084A1 CS257084A1 (en) 1985-06-13
CS239422B1 true CS239422B1 (en) 1986-01-16

Family

ID=5363194

Family Applications (1)

Application Number Title Priority Date Filing Date
CS842570A CS239422B1 (en) 1984-04-03 1984-04-03 Substituted benzothiazolium salts and a process for their preparation

Country Status (1)

Country Link
CS (1) CS239422B1 (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107580592A (en) * 2015-05-12 2018-01-12 巴斯夫欧洲公司 Sulfide compound as nitrification inhibitor

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN107580592A (en) * 2015-05-12 2018-01-12 巴斯夫欧洲公司 Sulfide compound as nitrification inhibitor
US11053175B2 (en) 2015-05-12 2021-07-06 Basf Se Thioether compounds as nitrification inhibitors
CN107580592B (en) * 2015-05-12 2022-03-04 巴斯夫欧洲公司 Thioether compounds as nitrification inhibitors

Also Published As

Publication number Publication date
CS257084A1 (en) 1985-06-13

Similar Documents

Publication Publication Date Title
CA1059141A (en) Microbicidal agents
SU1528316A3 (en) Method of producing derivatives of distamycin a or hydrochlorides thereof
SU1068034A3 (en) Process for preparing 3-aryloxy-3-phenylpropylamine(-)-enanthiomer 3-aryloxy-3-phe
US12024494B2 (en) Salt of LSD1 inhibitor and a polymorph thereof
DK1976826T3 (en) Organic derivatives, their salts and their use in the control of phytopathogens.
US12428414B2 (en) Methods for purifying isavuconazonium sulfate
JPS63211225A (en) Antitumoral spermine derivative
JP4001636B2 (en) Activated iodine derivatives for the treatment of cancer and AIDS
CS239422B1 (en) Substituted benzothiazolium salts and a process for their preparation
SU1389677A3 (en) Method of producing deriavives of 2-cyano-2-phenylacetic acid
SU495826A3 (en) The method of obtaining aminoalcohols
US4169950A (en) Amino-hydroxy-alkyl sulfonic acid zwitterions
US4079144A (en) Phenylimino-thiazolines and their use as acaricides
CN117342990B (en) A sulfonamide compound, a preparation method and application thereof, a pesticide preparation, a pharmaceutical
EP0508777A2 (en) Novel adenine derivatives and their use as plant growth regulators
CA1186686A (en) Nitrosourea derivatives
US20220024880A1 (en) Process route of compound of formula (iv), crystal form and preparation method therefor
SU654610A1 (en) Lodine methylate of b-dimethylaminoethyl ester of delta3-cyclohexenecarboxylic acid as plant growth regulator
SU833141A3 (en) Method of soy plant growth control
CS233443B1 (en) 2 * alkoxycarbonylmethylthio-3-alkylbenzothiazole salts and their preparation
JPS63211263A (en) Novel dipeptide
KR19980087487A (en) How to regulate algae
SU1098934A1 (en) 4-aminomethyl derivatives of 2-methyl-5-hydroxybenzimidazole having growth stimulating effect
JP2857461B2 (en) Dipeptide compound
RU1681488C (en) Derivatives 3-methyl-5-acenaphthenyl-2,4-pentadiene acid exhibiting antitranspiration activity